Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
Music producer Naughty Boy has apparently released ex-One Direction star Zayn Malik's first solo track.
A Malaysian court has found a man guilty of murdering two British medical students in Borneo.
A Liberal Democrat parliamentary candidate has said he deliberately caught HIV after years battling depression.